Global Neutropenia Biologic Drug Treatment Market Research Report 2025(Status and Outlook)

October 2025 | 159 pages | ID: G51A1D694028EN
Bosson Research

Abstracts

Report Overview

Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy, infections, bone marrow disorders, autoimmune disorders, and the use of specific drugs.

The global Neutropenia Biologic Drug Treatment market size was estimated at USD 2780.45 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.75% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Neutropenia Biologic Drug Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Neutropenia Biologic Drug Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neutropenia Biologic Drug Treatment market

Global Neutropenia Biologic Drug Treatment Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Teva Pharmaceutical
Amgen
Sanofi
Mylan(Fulphila)
Kyowa Kirin
Novartis
Spectrum Pharmaceuticals
Pfizer
Baxter International
Partner Therapeutics(Leukine)
BeyondSpring Pharmaceuticals
Cellerant Therapeutics
Enzychem Lifesciences Corporation
Myelo Therapeutics
Generon

Market Segmentation (by Type)

Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim

Market Segmentation (by Application)

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Neutropenia Biologic Drug Treatment Market
• Overview of the regional outlook of the Neutropenia Biologic Drug Treatment Market.

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neutropenia Biologic Drug Treatment Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Neutropenia Biologic Drug Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Neutropenia Biologic Drug Treatment
1.2 Key Market Segments
  1.2.1 Neutropenia Biologic Drug Treatment Segment by Type
  1.2.2 Neutropenia Biologic Drug Treatment Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Neutropenia Biologic Drug Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Neutropenia Biologic Drug Treatment Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Neutropenia Biologic Drug Treatment Product Life Cycle
3.3 Global Neutropenia Biologic Drug Treatment Sales by Manufacturers (2020-2025)
3.4 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neutropenia Biologic Drug Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neutropenia Biologic Drug Treatment Market Competitive Situation and Trends
  3.8.1 Neutropenia Biologic Drug Treatment Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Neutropenia Biologic Drug Treatment Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NEUTROPENIA BIOLOGIC DRUG TREATMENT INDUSTRY CHAIN ANALYSIS

4.1 Neutropenia Biologic Drug Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Neutropenia Biologic Drug Treatment Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Neutropenia Biologic Drug Treatment Market
5.7 ESG Ratings of Leading Companies

6 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2020-2025)
6.3 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Type (2020-2025)
6.4 Global Neutropenia Biologic Drug Treatment Price by Type (2020-2025)

7 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neutropenia Biologic Drug Treatment Market Sales by Application (2020-2025)
7.3 Global Neutropenia Biologic Drug Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Neutropenia Biologic Drug Treatment Sales Growth Rate by Application (2020-2025)

8 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET SALES BY REGION

8.1 Global Neutropenia Biologic Drug Treatment Sales by Region
  8.1.1 Global Neutropenia Biologic Drug Treatment Sales by Region
  8.1.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Region
8.2 Global Neutropenia Biologic Drug Treatment Market Size by Region
  8.2.1 Global Neutropenia Biologic Drug Treatment Market Size by Region
  8.2.2 Global Neutropenia Biologic Drug Treatment Market Size Market Share by Region
8.3 North America
  8.3.1 North America Neutropenia Biologic Drug Treatment Sales by Country
  8.3.2 North America Neutropenia Biologic Drug Treatment Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Neutropenia Biologic Drug Treatment Sales by Country
  8.4.2 Europe Neutropenia Biologic Drug Treatment Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Neutropenia Biologic Drug Treatment Sales by Region
  8.5.2 Asia Pacific Neutropenia Biologic Drug Treatment Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Neutropenia Biologic Drug Treatment Sales by Country
  8.6.2 South America Neutropenia Biologic Drug Treatment Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Neutropenia Biologic Drug Treatment Sales by Region
  8.7.2 Middle East and Africa Neutropenia Biologic Drug Treatment Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET PRODUCTION BY REGION

9.1 Global Production of Neutropenia Biologic Drug Treatment by Region(2020-2025)
9.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Neutropenia Biologic Drug Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neutropenia Biologic Drug Treatment Production
  9.4.1 North America Neutropenia Biologic Drug Treatment Production Growth Rate (2020-2025)
  9.4.2 North America Neutropenia Biologic Drug Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neutropenia Biologic Drug Treatment Production
  9.5.1 Europe Neutropenia Biologic Drug Treatment Production Growth Rate (2020-2025)
  9.5.2 Europe Neutropenia Biologic Drug Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neutropenia Biologic Drug Treatment Production (2020-2025)
  9.6.1 Japan Neutropenia Biologic Drug Treatment Production Growth Rate (2020-2025)
  9.6.2 Japan Neutropenia Biologic Drug Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neutropenia Biologic Drug Treatment Production (2020-2025)
  9.7.1 China Neutropenia Biologic Drug Treatment Production Growth Rate (2020-2025)
  9.7.2 China Neutropenia Biologic Drug Treatment Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Teva Pharmaceutical
  10.1.1 Teva Pharmaceutical Basic Information
  10.1.2 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Overview
  10.1.3 Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Market Performance
  10.1.4 Teva Pharmaceutical Business Overview
  10.1.5 Teva Pharmaceutical SWOT Analysis
  10.1.6 Teva Pharmaceutical Recent Developments
10.2 Amgen
  10.2.1 Amgen Basic Information
  10.2.2 Amgen Neutropenia Biologic Drug Treatment Product Overview
  10.2.3 Amgen Neutropenia Biologic Drug Treatment Product Market Performance
  10.2.4 Amgen Business Overview
  10.2.5 Amgen SWOT Analysis
  10.2.6 Amgen Recent Developments
10.3 Sanofi
  10.3.1 Sanofi Basic Information
  10.3.2 Sanofi Neutropenia Biologic Drug Treatment Product Overview
  10.3.3 Sanofi Neutropenia Biologic Drug Treatment Product Market Performance
  10.3.4 Sanofi Business Overview
  10.3.5 Sanofi SWOT Analysis
  10.3.6 Sanofi Recent Developments
10.4 Mylan(Fulphila)
  10.4.1 Mylan(Fulphila) Basic Information
  10.4.2 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Overview
  10.4.3 Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Market Performance
  10.4.4 Mylan(Fulphila) Business Overview
  10.4.5 Mylan(Fulphila) Recent Developments
10.5 Kyowa Kirin
  10.5.1 Kyowa Kirin Basic Information
  10.5.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Overview
  10.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Market Performance
  10.5.4 Kyowa Kirin Business Overview
  10.5.5 Kyowa Kirin Recent Developments
10.6 Novartis
  10.6.1 Novartis Basic Information
  10.6.2 Novartis Neutropenia Biologic Drug Treatment Product Overview
  10.6.3 Novartis Neutropenia Biologic Drug Treatment Product Market Performance
  10.6.4 Novartis Business Overview
  10.6.5 Novartis Recent Developments
10.7 Spectrum Pharmaceuticals
  10.7.1 Spectrum Pharmaceuticals Basic Information
  10.7.2 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Overview
  10.7.3 Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Market Performance
  10.7.4 Spectrum Pharmaceuticals Business Overview
  10.7.5 Spectrum Pharmaceuticals Recent Developments
10.8 Pfizer
  10.8.1 Pfizer Basic Information
  10.8.2 Pfizer Neutropenia Biologic Drug Treatment Product Overview
  10.8.3 Pfizer Neutropenia Biologic Drug Treatment Product Market Performance
  10.8.4 Pfizer Business Overview
  10.8.5 Pfizer Recent Developments
10.9 Baxter International
  10.9.1 Baxter International Basic Information
  10.9.2 Baxter International Neutropenia Biologic Drug Treatment Product Overview
  10.9.3 Baxter International Neutropenia Biologic Drug Treatment Product Market Performance
  10.9.4 Baxter International Business Overview
  10.9.5 Baxter International Recent Developments
10.10 Partner Therapeutics(Leukine)
  10.10.1 Partner Therapeutics(Leukine) Basic Information
  10.10.2 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Overview
  10.10.3 Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Market Performance
  10.10.4 Partner Therapeutics(Leukine) Business Overview
  10.10.5 Partner Therapeutics(Leukine) Recent Developments
10.11 BeyondSpring Pharmaceuticals
  10.11.1 BeyondSpring Pharmaceuticals Basic Information
  10.11.2 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Overview
  10.11.3 BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Market Performance
  10.11.4 BeyondSpring Pharmaceuticals Business Overview
  10.11.5 BeyondSpring Pharmaceuticals Recent Developments
10.12 Cellerant Therapeutics
  10.12.1 Cellerant Therapeutics Basic Information
  10.12.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Overview
  10.12.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Market Performance
  10.12.4 Cellerant Therapeutics Business Overview
  10.12.5 Cellerant Therapeutics Recent Developments
10.13 Enzychem Lifesciences Corporation
  10.13.1 Enzychem Lifesciences Corporation Basic Information
  10.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Overview
  10.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Market Performance
  10.13.4 Enzychem Lifesciences Corporation Business Overview
  10.13.5 Enzychem Lifesciences Corporation Recent Developments
10.14 Myelo Therapeutics
  10.14.1 Myelo Therapeutics Basic Information
  10.14.2 Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Overview
  10.14.3 Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Market Performance
  10.14.4 Myelo Therapeutics Business Overview
  10.14.5 Myelo Therapeutics Recent Developments
10.15 Generon
  10.15.1 Generon Basic Information
  10.15.2 Generon Neutropenia Biologic Drug Treatment Product Overview
  10.15.3 Generon Neutropenia Biologic Drug Treatment Product Market Performance
  10.15.4 Generon Business Overview
  10.15.5 Generon Recent Developments

11 NEUTROPENIA BIOLOGIC DRUG TREATMENT MARKET FORECAST BY REGION

11.1 Global Neutropenia Biologic Drug Treatment Market Size Forecast
11.2 Global Neutropenia Biologic Drug Treatment Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Neutropenia Biologic Drug Treatment Market Size Forecast by Country
  11.2.3 Asia Pacific Neutropenia Biologic Drug Treatment Market Size Forecast by Region
  11.2.4 South America Neutropenia Biologic Drug Treatment Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Neutropenia Biologic Drug Treatment by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Neutropenia Biologic Drug Treatment Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Neutropenia Biologic Drug Treatment by Type (2026-2033)
  12.1.2 Global Neutropenia Biologic Drug Treatment Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Neutropenia Biologic Drug Treatment by Type (2026-2033)
12.2 Global Neutropenia Biologic Drug Treatment Market Forecast by Application (2026-2033)
  12.2.1 Global Neutropenia Biologic Drug Treatment Sales (K Units) Forecast by Application
  12.2.2 Global Neutropenia Biologic Drug Treatment Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neutropenia Biologic Drug Treatment Market Size Comparison by Region (M USD)
Table 5. Global Neutropenia Biologic Drug Treatment Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Neutropenia Biologic Drug Treatment Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Neutropenia Biologic Drug Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Neutropenia Biologic Drug Treatment Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2024)
Table 10. Global Market Neutropenia Biologic Drug Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Neutropenia Biologic Drug Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Neutropenia Biologic Drug Treatment Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Neutropenia Biologic Drug Treatment Sales by Type (K Units)
Table 26. Global Neutropenia Biologic Drug Treatment Market Size by Type (M USD)
Table 27. Global Neutropenia Biologic Drug Treatment Sales (K Units) by Type (2020-2025)
Table 28. Global Neutropenia Biologic Drug Treatment Sales Market Share by Type (2020-2025)
Table 29. Global Neutropenia Biologic Drug Treatment Market Size (M USD) by Type (2020-2025)
Table 30. Global Neutropenia Biologic Drug Treatment Market Size Share by Type (2020-2025)
Table 31. Global Neutropenia Biologic Drug Treatment Price (USD/Unit) by Type (2020-2025)
Table 32. Global Neutropenia Biologic Drug Treatment Sales (K Units) by Application
Table 33. Global Neutropenia Biologic Drug Treatment Market Size by Application
Table 34. Global Neutropenia Biologic Drug Treatment Sales by Application (2020-2025) & (K Units)
Table 35. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2020-2025)
Table 36. Global Neutropenia Biologic Drug Treatment Market Size by Application (2020-2025) & (M USD)
Table 37. Global Neutropenia Biologic Drug Treatment Market Share by Application (2020-2025)
Table 38. Global Neutropenia Biologic Drug Treatment Sales Growth Rate by Application (2020-2025)
Table 39. Global Neutropenia Biologic Drug Treatment Sales by Region (2020-2025) & (K Units)
Table 40. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2020-2025)
Table 41. Global Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025) & (M USD)
Table 42. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2020-2025)
Table 43. North America Neutropenia Biologic Drug Treatment Sales by Country (2020-2025) & (K Units)
Table 44. North America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Neutropenia Biologic Drug Treatment Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Neutropenia Biologic Drug Treatment Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025) & (M USD)
Table 49. South America Neutropenia Biologic Drug Treatment Sales by Country (2020-2025) & (K Units)
Table 50. South America Neutropenia Biologic Drug Treatment Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Neutropenia Biologic Drug Treatment Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size by Region (2020-2025) & (M USD)
Table 53. Global Neutropenia Biologic Drug Treatment Production (K Units) by Region(2020-2025)
Table 54. Global Neutropenia Biologic Drug Treatment Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Region (2020-2025)
Table 56. Global Neutropenia Biologic Drug Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Neutropenia Biologic Drug Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Neutropenia Biologic Drug Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Neutropenia Biologic Drug Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Neutropenia Biologic Drug Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Teva Pharmaceutical Basic Information
Table 62. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Product Overview
Table 63. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Teva Pharmaceutical Business Overview
Table 65. Teva Pharmaceutical SWOT Analysis
Table 66. Teva Pharmaceutical Recent Developments
Table 67. Amgen Basic Information
Table 68. Amgen Neutropenia Biologic Drug Treatment Product Overview
Table 69. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Amgen Business Overview
Table 71. Amgen SWOT Analysis
Table 72. Amgen Recent Developments
Table 73. Sanofi Basic Information
Table 74. Sanofi Neutropenia Biologic Drug Treatment Product Overview
Table 75. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Sanofi Business Overview
Table 77. Sanofi SWOT Analysis
Table 78. Sanofi Recent Developments
Table 79. Mylan(Fulphila) Basic Information
Table 80. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Product Overview
Table 81. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Mylan(Fulphila) Business Overview
Table 83. Mylan(Fulphila) Recent Developments
Table 84. Kyowa Kirin Basic Information
Table 85. Kyowa Kirin Neutropenia Biologic Drug Treatment Product Overview
Table 86. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Kyowa Kirin Business Overview
Table 88. Kyowa Kirin Recent Developments
Table 89. Novartis Basic Information
Table 90. Novartis Neutropenia Biologic Drug Treatment Product Overview
Table 91. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Spectrum Pharmaceuticals Basic Information
Table 95. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Product Overview
Table 96. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Spectrum Pharmaceuticals Business Overview
Table 98. Spectrum Pharmaceuticals Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer Neutropenia Biologic Drug Treatment Product Overview
Table 101. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Baxter International Basic Information
Table 105. Baxter International Neutropenia Biologic Drug Treatment Product Overview
Table 106. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Baxter International Business Overview
Table 108. Baxter International Recent Developments
Table 109. Partner Therapeutics(Leukine) Basic Information
Table 110. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Product Overview
Table 111. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Partner Therapeutics(Leukine) Business Overview
Table 113. Partner Therapeutics(Leukine) Recent Developments
Table 114. BeyondSpring Pharmaceuticals Basic Information
Table 115. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Product Overview
Table 116. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. BeyondSpring Pharmaceuticals Business Overview
Table 118. BeyondSpring Pharmaceuticals Recent Developments
Table 119. Cellerant Therapeutics Basic Information
Table 120. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Overview
Table 121. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Cellerant Therapeutics Business Overview
Table 123. Cellerant Therapeutics Recent Developments
Table 124. Enzychem Lifesciences Corporation Basic Information
Table 125. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Overview
Table 126. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Enzychem Lifesciences Corporation Business Overview
Table 128. Enzychem Lifesciences Corporation Recent Developments
Table 129. Myelo Therapeutics Basic Information
Table 130. Myelo Therapeutics Neutropenia Biologic Drug Treatment Product Overview
Table 131. Myelo Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Myelo Therapeutics Business Overview
Table 133. Myelo Therapeutics Recent Developments
Table 134. Generon Basic Information
Table 135. Generon Neutropenia Biologic Drug Treatment Product Overview
Table 136. Generon Neutropenia Biologic Drug Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Generon Business Overview
Table 138. Generon Recent Developments
Table 139. Global Neutropenia Biologic Drug Treatment Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Neutropenia Biologic Drug Treatment Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Neutropenia Biologic Drug Treatment Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Neutropenia Biologic Drug Treatment Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Neutropenia Biologic Drug Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Neutropenia Biologic Drug Treatment Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Neutropenia Biologic Drug Treatment Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Neutropenia Biologic Drug Treatment Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Neutropenia Biologic Drug Treatment Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Neutropenia Biologic Drug Treatment Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Neutropenia Biologic Drug Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neutropenia Biologic Drug Treatment Market Size (M USD), 2024-2033
Figure 5. Global Neutropenia Biologic Drug Treatment Market Size (M USD) (2020-2033)
Figure 6. Global Neutropenia Biologic Drug Treatment Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neutropenia Biologic Drug Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neutropenia Biologic Drug Treatment Product Life Cycle
Figure 13. Neutropenia Biologic Drug Treatment Sales Share by Manufacturers in 2024
Figure 14. Global Neutropenia Biologic Drug Treatment Revenue Share by Manufacturers in 2024
Figure 15. Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neutropenia Biologic Drug Treatment Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neutropenia Biologic Drug Treatment Revenue in 2024
Figure 18. Industry Chain Map of Neutropenia Biologic Drug Treatment
Figure 19. Global Neutropenia Biologic Drug Treatment Market PEST Analysis
Figure 20. Global Neutropenia Biologic Drug Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neutropenia Biologic Drug Treatment Market Share by Type
Figure 27. Sales Market Share of Neutropenia Biologic Drug Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Neutropenia Biologic Drug Treatment by Type in 2024
Figure 29. Market Size Share of Neutropenia Biologic Drug Treatment by Type (2020-2025)
Figure 30. Market Size Share of Neutropenia Biologic Drug Treatment by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neutropenia Biologic Drug Treatment Market Share by Application
Figure 33. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Neutropenia Biologic Drug Treatment Sales Market Share by Application in 2024
Figure 35. Global Neutropenia Biologic Drug Treatment Market Share by Application (2020-2025)
Figure 36. Global Neutropenia Biologic Drug Treatment Market Share by Application in 2024
Figure 37. Global Neutropenia Biologic Drug Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neutropenia Biologic Drug Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Neutropenia Biologic Drug Treatment Market Size Market Share by Region (2020-2025)
Figure 40. North America Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2024
Figure 43. North America Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2024
Figure 45. U.S. Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neutropenia Biologic Drug Treatment Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Neutropenia Biologic Drug Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neutropenia Biologic Drug Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neutropenia Biologic Drug Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2024
Figure 53. Europe Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2024
Figure 55. Germany Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neutropenia Biologic Drug Treatment Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Neutropenia Biologic Drug Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neutropenia Biologic Drug Treatment Market Size Market Share by Region in 2024
Figure 68. China Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neutropenia Biologic Drug Treatment Sales and Growth Rate (K Units)
Figure 79. South America Neutropenia Biologic Drug Treatment Sales Market Share by Country in 2024
Figure 80. South America Neutropenia Biologic Drug Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Neutropenia Biologic Drug Treatment Market Size Market Share by Country in 2024
Figure 82. Brazil Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neutropenia Biologic Drug Treatment Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Neutropenia Biologic Drug Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neutropenia Biologic Drug Treatment Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neutropenia Biologic Drug Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Neutropenia Biologic Drug Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neutropenia Biologic Drug Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Neutropenia Biologic Drug Treatment Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Neutropenia Biologic Drug Treatment Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Neutropenia Biologic Drug Treatment Production (K Units) Growth Rate (2020-2025)
Figure 106. China Neutropenia Biologic Drug Treatment Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Neutropenia Biologic Drug Treatment Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Neutropenia Biologic Drug Treatment Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Neutropenia Biologic Drug Treatment Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Neutropenia Biologic Drug Treatment Market Share Forecast by Type (2026-2033)
Figure 111. Global Neutropenia Biologic Drug Treatment Sales Forecast by Application (2026-2033)
Figure 112. Global Neutropenia Biologic Drug Treatment Market Share Forecast by Application (2026-2033)